These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35146525)

  • 1. Neutrophil:lymphocyte ratio correlates with the uremic toxin indoxyl sulfate and predicts the risk of death in patients on hemodialysis.
    Lano G; Sallée M; Pelletier M; Bataille S; Fraisse M; McKay N; Brunet P; Dou L; Burtey S
    Nephrol Dial Transplant; 2022 Nov; 37(12):2528-2537. PubMed ID: 35146525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.
    Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of uremic toxins in advanced chronic kidney disease patients on maintenance hemodialysis by LC-ESI-MS/MS.
    Ragi N; Pallerla P; Babi Reddy Gari AR; Lingampelly SS; Ketavarapu V; Addipilli R; Chirra N; Kantevari S; Yadla M; Sripadi P
    Metabolomics; 2023 Feb; 19(3):14. PubMed ID: 36826619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein/Fiber Index Modulates Uremic Toxin Concentrations in Hemodialysis Patients.
    Ebersolt M; Santana Machado T; Mallmann C; Mc-Kay N; Dou L; Bouchouareb D; Brunet P; Burtey S; Sallée M
    Toxins (Basel); 2022 Aug; 14(9):. PubMed ID: 36136527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there an association between the plasma levels of uremic toxins from gut microbiota and anemia in patients on hemodialysis?
    Capo-Chichi JCC; Borges NA; de Vargas Reis DCM; Nakao LS; Mafra D
    Int Urol Nephrol; 2022 Jun; 54(6):1271-1277. PubMed ID: 34561817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
    Lin CJ; Wu V; Wu PC; Wu CJ
    PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
    Yamamoto S
    Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.
    Kaminski TW; Pawlak K; Karbowska M; Znorko B; Mor AL; Mysliwiec M; Pawlak D
    Int Urol Nephrol; 2019 Mar; 51(3):491-502. PubMed ID: 30617956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Synbiotic Supplementation on Uremic Toxins, Oxidative Stress, and Inflammation in Hemodialysis Patients-Results of an Uncontrolled Prospective Single-Arm Study.
    Kuskunov T; Tilkiyan E; Doykov D; Boyanov K; Bivolarska A; Hristov B
    Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629672
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictive value of protein-bound uremic toxins for heart failure in patients with chronic kidney disease.
    Zwaenepoel B; De Backer T; Glorieux G; Verbeke F
    ESC Heart Fail; 2024 Feb; 11(1):466-474. PubMed ID: 38041505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients.
    Wu PH; Lin YT; Chiu YW; Baldanzi G; Huang JC; Liang SS; Lee SC; Chen SC; Hsu YL; Kuo MC; Hwang SJ
    Sci Rep; 2021 Feb; 11(1):3786. PubMed ID: 33589722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.
    Bataille S; Pelletier M; Sallée M; Berland Y; McKay N; Duval A; Gentile S; Mouelhi Y; Brunet P; Burtey S
    BMC Nephrol; 2017 Jul; 18(1):251. PubMed ID: 28747155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut-Derived Uremic Toxins in CKD: An Improved Approach for the Evaluation of Serum Indoxyl Sulfate in Clinical Practice.
    Caggiano G; Amodio L; Stasi A; Colabufo NA; Colangiulo S; Pesce F; Gesualdo L
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of indoxyl sulfate with heart failure among patients on hemodialysis.
    Cao XS; Chen J; Zou JZ; Zhong YH; Teng J; Ji J; Chen ZW; Liu ZH; Shen B; Nie YX; Lv WL; Xiang FF; Tan X; Ding XQ
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):111-9. PubMed ID: 25332316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress of the uremic toxin indoxyl sulfate in cardiovascular complication of end-stage renal diseases].
    Guo CC; Xia WW; Zhang AH
    Sheng Li Xue Bao; 2018 Dec; 70(6):657-662. PubMed ID: 30560276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
    Ito S; Yoshida M
    Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome.
    van Gelder MK; Middel IR; Vernooij RWM; Bots ML; Verhaar MC; Masereeuw R; Grooteman MP; Nubé MJ; van den Dorpel MA; Blankestijn PJ; Rookmaaker MB; Gerritsen KGF
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32272776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Indoxyl Sulfate on Coronary Plaques in Patients on Hemodialysis.
    Asami M; Tanabe K; Ito S; Yoshida E; Aoki J; Tanimoto S; Horiuchi Y; Yoshida M
    Int Heart J; 2018 May; 59(3):489-496. PubMed ID: 29743417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoxyl Sulfate and Incident Peripheral Artery Disease in Hemodialysis Patients.
    Lin TY; Chou HH; Huang HL; Hung SC
    Toxins (Basel); 2020 Nov; 12(11):. PubMed ID: 33147880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.